Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of Rcbtb1 Knockout Mice and Evaluation of AAV2-RCBTB1 Gene Replacement Therapy.

Translational vision science & technology·2026
Same author

Inpatient versus outpatient management of bilateral optic nerve head elevation presentation to a tertiary emergency department.

BMJ neurology open·2026
Same author

Radial outer retina reflectivity (RORR) sign in LAMP2-associated retinopathy.

Acta ophthalmologica·2026
Same author

Perspectives on the Teaching and Learning of Non-Verbal Communication Skills: Tutor, Simulated Patient and Student Experiences of a Rapid Transition to Online Learning.

Medical science educator·2026
Same author

The longitudinal relationship between carotid arterial disease and retinopathy complicating type 2 diabetes: The Fremantle diabetes study phase II.

Journal of diabetes and its complications·2026
Same author

Corrigendum to Peripapillary Retinoschisis: The Expanded Spectrum and New Insights From Multimodal Imaging. Am J Ophthalmol. 2026;282:26-40.

American journal of ophthalmology·2026

Related Experiment Video

Updated: Aug 6, 2025

In vivo Imaging of Optic Nerve Fiber Integrity by Contrast-Enhanced MRI in Mice
11:38

In vivo Imaging of Optic Nerve Fiber Integrity by Contrast-Enhanced MRI in Mice

Published on: July 22, 2014

13.5K

Serum miRNA modulations indicate changes in retinal morphology.

Riemke Aggio-Bruce1,2, Ulrike Schumann1,3, Adrian V Cioanca1

  • 1The John Curtin School of Medical Research, The Australian National University, Acton, ACT, Australia.

Frontiers in Molecular Neuroscience
|March 20, 2023
PubMed
Summary
This summary is machine-generated.

Serum microRNAs (miRNAs) show promise as early diagnostic biomarkers for age-related macular degeneration (AMD). This study identified a preliminary serum miRNA signature for AMD progression by combining mouse models and human patient data.

Keywords:
age-related macular degenerationdiagnosticsmicroRNAneurodegenerationserum miRNAs

More Related Videos

Morphometric Analyses of Retinal Sections
14:33

Morphometric Analyses of Retinal Sections

Published on: February 19, 2012

10.3K
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

3.3K

Related Experiment Videos

Last Updated: Aug 6, 2025

In vivo Imaging of Optic Nerve Fiber Integrity by Contrast-Enhanced MRI in Mice
11:38

In vivo Imaging of Optic Nerve Fiber Integrity by Contrast-Enhanced MRI in Mice

Published on: July 22, 2014

13.5K
Morphometric Analyses of Retinal Sections
14:33

Morphometric Analyses of Retinal Sections

Published on: February 19, 2012

10.3K
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

3.3K

Area of Science:

  • Ophthalmology
  • Biomarker Discovery
  • Molecular Biology

Background:

  • Age-related macular degeneration (AMD) is a leading cause of vision loss, diagnosed via retinal morphology.
  • MicroRNAs (miRNAs) are explored as biomarkers for neurological diseases, including AMD, but studies lack overlap due to biological complexity and varied designs.
  • A novel approach using preclinical models and clinical samples is needed to establish a reliable serum signature for AMD progression.

Purpose of the Study:

  • To determine a serum signature indicative of age-related macular degeneration (AMD) progression.
  • To validate the use of serum microRNAs (miRNAs) as early diagnostic biomarkers for retinal degeneration.
  • To investigate the overlap of miRNA expression changes between a preclinical mouse model and human AMD patients.

Main Methods:

  • Serum miRNAs were extracted from mice subjected to photo-oxidative damage and from human patients with AMD.
  • ~800 miRNAs were quantified using OpenArray™, with differential abundance analyzed using HTqPCR and DAVID.
  • MiRNA expression changes were correlated with retinal histological indicators and compared between the mouse model and human samples.

Main Results:

  • Differential miRNA abundance was detected in both the mouse model and human AMD samples, correlating with inflammatory pathways and retinal histological changes.
  • Findings in the mouse serum samples were successfully aligned with those observed in clinical patient samples.
  • A preliminary serum miRNA signature associated with AMD progression was identified.

Conclusions:

  • Serum miRNAs serve as a valid diagnostic tool, reflecting retinal health changes for early detection of degeneration.
  • The combined approach of preclinical models and human samples identified a preliminary serum miRNA signature for AMD.
  • This study provides a foundation for developing a diagnostic serum miRNA panel for early AMD detection.